- Home
- CEVA vs KURA Comparison
CEVA vs KURA Comparison
Compare CEVA & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEVA
- KURA
- Stock Information
- Founded
- CEVA 1999
- KURA 2014
- Country
- CEVA United States
- KURA United States
- Employees
- CEVA N/A
- KURA N/A
- Industry
- CEVA Semiconductors
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CEVA Technology
- KURA Health Care
- Exchange
- CEVA Nasdaq
- KURA Nasdaq
- Market Cap
- CEVA 508.9M
- KURA 561.9M
- IPO Year
- CEVA 2000
- KURA N/A
- Fundamental
- Price
- CEVA $22.44
- KURA $6.13
- Analyst Decision
- CEVA Strong Buy
- KURA Strong Buy
- Analyst Count
- CEVA 5
- KURA 12
- Target Price
- CEVA $35.60
- KURA $24.50
- AVG Volume (30 Days)
- CEVA 264.2K
- KURA 1.4M
- Earning Date
- CEVA 08-11-2025
- KURA 08-07-2025
- Dividend Yield
- CEVA N/A
- KURA N/A
- EPS Growth
- CEVA N/A
- KURA N/A
- EPS
- CEVA N/A
- KURA N/A
- Revenue
- CEVA $109,112,000.00
- KURA $67,991,000.00
- Revenue This Year
- CEVA $4.47
- KURA $125.04
- Revenue Next Year
- CEVA $16.50
- KURA $83.75
- P/E Ratio
- CEVA N/A
- KURA N/A
- Revenue Growth
- CEVA 17.04
- KURA N/A
- 52 Week Low
- CEVA $16.02
- KURA $5.41
- 52 Week High
- CEVA $38.94
- KURA $23.48
- Technical
- Relative Strength Index (RSI)
- CEVA 57.19
- KURA 51.23
- Support Level
- CEVA $21.92
- KURA $5.65
- Resistance Level
- CEVA $23.70
- KURA $6.51
- Average True Range (ATR)
- CEVA 0.79
- KURA 0.27
- MACD
- CEVA 0.10
- KURA 0.06
- Stochastic Oscillator
- CEVA 66.38
- KURA 59.68
About CEVA CEVA Inc.
CEVA Inc is a licensor of signal-processing intellectual property. Through partnerships with semiconductor companies and original equipment manufacturers globally, the company helps produce devices for a range of end markets. OEMs and semiconductor companies choose to sell products with CEVA equipment to wireless, consumer, automotive, and Internet of Things companies. Revenue is derived primarily from licensing fees and related revenue, and royalties generated from the shipments of products utilizing its intellectual properties. CEVA also engages in the training and sale of development systems.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.